Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue Sarcoma
✍ Scribed by Andrew J. Hayes; Susan J. Neuhaus; Matthew A. Clark; J. Meirion Thomas
- Book ID
- 111771706
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 343 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1068-9265
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Since 1992, isolated limb perfusion (ILP) with tumor necrosis factor‐α (TNFα) and melphalan has been used for the treatment of patients with unresectable soft tissue sarcomas of the extremities. The authors retrospectively studied the results of limb salvage surgery using
## Background and Objectives: The prognosis for recurrent multifocal limb soft tissue sarcoma (STS) is dismal due to systemic spread. However, many of these patients undergo amputation due to ineffective local control. The purpose of the present study was to determine whether isolated limb perfusi